Decreasing hepatic vascular tone by liver-specific NO donors: wishful thinking or a promising reality?

被引：8
作者：
Bosch, J [1 ]
机构：
[1] Univ Barcelona, IDIBAPS, Hosp Clin, IMD,Liver Unit,Hepat Haemodynam Lab, E-08036 Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 39卷 / 06期
关键词：
D O I：
10.1016/j.jhep.2003.10.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1072 / 1075
页数：4
相关论文
共 43 条
[1]   CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION [J].
ALBILLOS, A ;
LLEDO, JL ;
ROSSI, I ;
PEREZPARAMO, M ;
TABUENCA, MJ ;
BANARES, R ;
IBORRA, J ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1995, 109 (04) :1257-1265
[2]   Angiotensin II induces contraction and proliferation of human hepatic stellate cells [J].
Bataller, R ;
Ginès, P ;
Nicolás, JM ;
Görbig, MN ;
Garcia-Ramallo, E ;
Gasull, X ;
Bosch, J ;
Arroyo, V ;
Rodés, J .
GASTROENTEROLOGY, 2000, 118 (06) :1149-1156
[3]   Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis [J].
Bellis, L ;
Berzigotti, A ;
Abraldes, JG ;
Moitinho, E ;
García-Pagán, JC ;
Bosch, J ;
Rodés, J .
HEPATOLOGY, 2003, 37 (02) :378-384
[4]   REDUCTION OF THE INCREASED PORTAL VASCULAR-RESISTANCE OF THE ISOLATED PERFUSED CIRRHOTIC RAT-LIVER BY VASODILATORS [J].
BHATHAL, PS ;
GROSSMAN, HJ .
JOURNAL OF HEPATOLOGY, 1985, 1 (04) :325-337
[5]  
BOSCH J, 1983, HEPATOLOGY, V3, P1002
[6]   Current management of portal hypertension [J].
Bosch, J ;
Abraldes, JG ;
Groszmann, R .
JOURNAL OF HEPATOLOGY, 2003, 38 :S54-S68
[7]   NEW APPROACHES IN THE PHARMACOLOGICAL TREATMENT OF PORTAL-HYPERTENSION [J].
BOSCH, J ;
GARCIAPAGAN, JC ;
FEU, F ;
LUCA, A ;
FERNANDEZ, M ;
PIZCUETA, P ;
RODES, J .
JOURNAL OF HEPATOLOGY, 1993, 17 :S41-S45
[8]   A la carte treatment of portal hypertension:: Adapting medical therapy to hemodynamic response for the prevention of bleeding [J].
Bureau, C ;
Péron, JM ;
Alric, L ;
Morales, J ;
Sanchez, J ;
Barange, K ;
Payen, JL ;
Vinel, JP .
HEPATOLOGY, 2002, 36 (06) :1361-1366
[9]   Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers [J].
Dudenhoefer, AA ;
Loureiro-Silva, MR ;
Cadelina, GW ;
Gupta, T ;
Groszmann, RJ .
HEPATOLOGY, 2002, 36 (02) :381-385
[10]   NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver [J].
Fiorucci, S ;
Antonelli, E ;
Brancaleone, V ;
Sanpaolol, L ;
Orlandi, S ;
Distrutti, E ;
Acuto, G ;
Clerici, C ;
Baldoni, M ;
Del Soldato, P ;
Morelli, A .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :932-939
12345